Quoin Pharmaceuticals, Ltd. American Depositary Shares
Symbol: QNRX (NASDAQ)
15.77
▼ (-2.47%) -0.400
Company Description:
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Key Stats
- Today's Open: $16.847
- Today's High: $17.11
- Today's Low: $15.765
- Today's Volume: 135
- Yesterday Close: $16.17
- Yesterday High: $17.84
- Yesterday Low: $15.26
- Yesterday Volume: 272.60K
- Last Min Volume: 2
- Last Min High: $15.77
- Last Min Low: $15.77
- Last Min VWAP: $15.77
Company Profile
- Name: Quoin Pharmaceuticals, Ltd. American Depositary Shares
- Website: https://www.quoinpharma.com
- Listed Date: 2021-10-28
- Location: KFAR SABA, L3
- Market Status: Active
- CIK Number: 0001671502
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.87M
- Round Lot: 100
- Outstanding Shares: 603.32K
- Asset Type: ADRC
RECENT FILINGS FOR QNRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 8-K | View |
| 2025-10-15 | 4 | View |
| 2025-10-15 | 8-K | View |
| 2025-09-08 | 3 | View |
| 2025-08-27 | S-8 | View |
| 2025-08-27 | 8-K | View |
| 2025-08-25 | S-8 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-21 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-17 | ARS | View |
| 2025-07-17 | DEF 14A | View |
| 2025-07-08 | 8-K | View |
| 2025-07-07 | PRE 14A | View |
| 2025-06-25 | 8-K | View |
| 2025-06-20 | 8-K | View |
| 2025-06-13 | 4/A | View |
Latest News on QNRX